New York Times: Breast implants linked to rare cancer are recalled worldwide
Rating: 4.5 Stars
- This is a well-written article that is factually correct and well-sourced.
- The statistics and scientific information are accurate.
- The headline is accurate.
- The lede states that Allergan implants are linked to cancer which is not incorrect could be more precisely stated: Allergan BIOCELL implants (not all implants) are linked to BIA-ALCL.
CNN: Worldwide recall issued for textured breast implants tied to rare cancer
Rating: 4.5 Stars
- This article is a clear and easy to read.
- There is good sourcing of commentary about this FDA recall from a variety of experts.
- The statistics and scientific information as well as the headline and lede are accurate.
- There is not much context of the field or discussion of the differences between implants or associated data.
USA Today: FDA recall: A dozen women with Allergan textured breast implants have died from rare cancer
Rating: 4.0 Stars
- This article is brief and is easy to read.
- Due to the short length, this article is does not provide a balanced perspective and doesn't include the limitation of this recall.
- There is one major inaccuracy. The article states that the FDA stated "significant increase in known cases". This is slightly misleading. The implication is that rates of BIA-ALCL are rising. It is not clear if this is an increase in rate or better reporting of existing cases given more widespread media coverage. Rare disease cases are known to be under-reported typically. The overall rate of BIA-ALCL is low and the vast majority of women with these breast implants do not get BIA-ALCL; this is not described well.
CBS News: Textured breast implant recipient on cancer diagnosis: It was "total shock"
Rating: 2 stars
- The headline is sensationalistic. The phrase"total shock" suggests that the possibility of complications from breast cancer implants including rare lypmphoma were surprising. However the possibility of BIA-ALCL while rare is are not new. The FDA began following this issue in 2011. BIA-ALCL is still a very rare disease.
- This is not a balanced article. The vast majority of women with textured breast implants do not develop BIa-ALCL which is not conveyed well.
- This article discusses Mentor implants (used by the patient they interviewed who has BIA-ALCL) extensively although the recall is only of Allergan's BIOCELL textured implants and expanders. There is no data implicating other textured implants at this time. They do not discuss whether this patient had any other implant which may confound the data.